MTOR and chondrosarcoma: A pivotal study by Vares et al. (2020) proposes an innovative approach using rapamycin to inhibit the mTOR pathway, along with a miR-34 mimic, as a strategy to break down the radioresistance commonly observed in cancer stem cells within chondrosarcoma during carbon-ion therapy [44].